Limits on Medicare's ability to control rising spending on cancer drugs.
Bach
Peter B
PB
Health Outcomes Research Group, Memorial Sloan-Kettering Cancer Center, New York, USA.
D000970:Antineoplastic Agents / Q000191:economics*; D003363:Cost Control; D016527:Drug Costs / Q000331:legislation & jurisprudence / Q000639:trends*; D005102:Health Expenditures / Q000639:trends; D006291:Health Policy; D006278:Medicare / Q000331:legislation & jurisprudence*; D012051:Reimbursement Mechanisms; D013219:State Government; D014481:United States
D000970:Antineoplastic Agents